Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-24

Clinical Trial Update: Efficacy of Lapaquistat Acetate Alone or Combined With Rosuvastatin in Subjects With Hypercholesterolemia [Phase 3]

View source ↗

Summary

Phase 3 trial update reports on the efficacy of lapaquistat acetate alone or in combination with rosuvastatin in subjects with hypercholesterolemia, with the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lapaquistat Acetate (lapaquistat acetate)
  • Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Takeda | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED